ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer.

Charlene Waryah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.